Following a full heart transplant on an 11-year-old patient, their valves were donated to a 14-year old patient and a now 9-year-old patient, according to a Feb. 27 news release from Duke Health.
“The current standard of care for pediatric heart valve replacement uses preserved non-living tissue or mechanical valves, which do not grow along with the child,” the release said. “As a result, recipients require multiple future valve replacement surgeries and blood thinners for mechanical valves.”
Research shows the living valves can continue to grow as the patient grows, according to the release.
Atlanta-based Georgia Tech researchers said they have developed a 3D-printed, bioresorbable heart valve that promotes tissue regeneration within the heart.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
